Search

Your search keyword '"Connors, Jean Marie"' showing total 13 results
Start Over Author "Connors, Jean Marie" Search Limiters Full Text
13 results on '"Connors, Jean Marie"'

3. ISTH guidelines for antithrombotic treatment in COVID‐19

Author

Schulman, Sam, Sholzberg, Michelle, Spyropoulos, Alex C., Zarychanski, Ryan, Resnick, Helaine E., Bradbury, Charlotte A., Connors, Jean Marie, Falanga, Anna, Iba, Toshiaki, Kaatz, Scott, Levy, Jerrold H., Middeldorp, Saskia, Minichiello, Tracy, Ramacciotti, Eduardo, Samama, Charles Marc, Thachil, Jecko, Broxmeyer, Lisa, and International Society on Thrombosis and Haemostasis

Published
2022
Full Text
View/download PDF

7. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day

Author

Potere, Nicola, primary, Barco, Stefano, additional, Mahé, Isabelle, additional, Cesarman‐Maus, Gabriela, additional, Angchaisuksiri, Pantep, additional, Leader, Avi, additional, Okoye, Helen C., additional, Olayemi, Edeghonghon, additional, Ay, Cihan, additional, Carrier, Marc, additional, Connors, Jean Marie, additional, Farmakis, Ioannis T., additional, Fumagalli, Riccardo M., additional, Jing, Zhi‐Cheng, additional, Lee, Lai Heng, additional, McLintock, Claire, additional, Ní Ainle, Fionnuala, additional, Giannakoulas, George, additional, Goto, Shinya, additional, Guillermo Esposito, Maria Cecilia, additional, Jara‐Palomares, Luis, additional, Szlaszynska, Marta, additional, Tan, Chee Wee, additional, Van Es, Nick, additional, Wang, Tzu‐Fei, additional, Hunt, Beverley J., additional, and Di Nisio, Marcello, additional

Published
2022
Full Text
View/download PDF

9. The authors reply

Author

Iba, Toshiaki, Levy, Jerrold H., Levi, Marcel, Connors, Jean Marie, and Thachil, Jecko

Subjects
SARS-CoV-2, COVID-19, Humans, Blood Coagulation Disorders, Letters to the Editor, Critical Care and Intensive Care Medicine, Letter to the Editor
Published
2020
Full Text
View/download PDF

10. ISTHguidelines for antithrombotic treatment in COVID‐19

Author

Schulman, Sam, Sholzberg, Michelle, Spyropoulos, Alex C., Zarychanski, Ryan, Resnick, Helaine E., Bradbury, Charlotte A., Broxmeyer, Lisa, Connors, Jean Marie, Falanga, Anna, Iba, Toshiaki, Kaatz, Scott, Levy, Jerrold H., Middeldorp, Saskia, Minichiello, Tracy, Ramacciotti, Eduardo, Samama, Charles Marc, and Thachil, Jecko

Abstract

Antithrombotic agents reduce risk of thromboembolism in severely ill patients. Patients with coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins. Optimal dosing and timing of these treatments and benefits of other antithrombotic agents remain unclear. In October 2021, ISTH assembled an international panel of content experts, patient representatives, and a methodologist to develop recommendations on anticoagulants and antiplatelet agents for patients with COVID‐19 in different clinical settings. We used the American College of Cardiology Foundation/American Heart Association methodology to assess level of evidence (LOE) and class of recommendation (COR). Only recommendations with LOE A or B were included. Panelists agreed on 12 recommendations: three for non‐hospitalized, five for non–critically ill hospitalized, three for critically ill hospitalized, and one for post‐discharge patients. Two recommendations were based on high‐quality evidence, the remainder on moderate‐quality evidence. Among non–critically ill patients hospitalized for COVID‐19, the panel gave a strong recommendation (a) for use of prophylactic dose of low molecular weight heparin or unfractionated heparin (LMWH/UFH) (COR 1); (b) for select patients in this group, use of therapeutic dose LMWH/UFH in preference to prophylactic dose (COR 1); but (c) against the addition of an antiplatelet agent (COR 3). Weak recommendations favored (a) sulodexide in non‐hospitalized patients, (b) adding an antiplatelet agent to prophylactic LMWH/UFH in select critically ill, and (c) prophylactic rivaroxaban for select patients after discharge (all COR 2b). Recommendations in this guideline are based on high‐/moderate‐quality evidence available through March 2022. Focused updates will incorporate future evidence supporting changes to these recommendations.

Published
2022
Full Text
View/download PDF

11. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19

Author

Spyropoulos, Alex C., primary, Levy, Jerrold H., additional, Ageno, Walter, additional, Connors, Jean Marie, additional, Hunt, Beverley J., additional, Iba, Toshiaki, additional, Levi, Marcel, additional, Samama, Charles Marc, additional, Thachil, Jecko, additional, Giannis, Dimitrios, additional, and Douketis, James D., additional

Published
2020
Full Text
View/download PDF

13. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth

Author

Papathanassoglou, Elizabeth, Christou, Helen, Connors, Jean Marie, and Παπαθανάσογλου, Ελισάβετ

Subjects
Leptin, Endocrinology, Metabolism, Hydrocortisone, Birth weight, MEDICAL AND HEALTH SCIENCES, Insulin, Fetus--Development
Abstract

The insulin-like growth factor (IGF) system is the dominant endocrine regulator of fetal growth, whereas insulin has a permissive role. Although a role for leptin in fetal growth has been suggested recently, the mechanism by which leptin may be related to fetal growth is not known; but leptin may interact with the IGF system in utero as it does in the extrauterine life. In the context of a hospital-based case control study, we collected anthropometric and demographic data and measured serum leptin, IGF-I, IGF-II, insulin, cortisol, and IGF binding protein 3 concentrations in 142 cord blood samples from full-term deliveries. Cord leptin, IGF-I, and insulin levels correlated positively with birth weight (r = 0.46, r = 0.41, and r = 0.21, respectively, P < 0.01) by univariate analysis and were significantly higher in large-for-gestational-age (LGA) infants, compared with appropriate-for-gestational-age (AGA) infants. Cord leptin concentrations correlated with insulin levels (r = 0.36, P

Published
2001

Catalog

Books, media, physical & digital resources
See catalog results